#PCBCommunity |🚀 #OrikineBio rep 2,7 M€ d’inversió del #CDTI Innovación i les gestores de fons #Asabys Partners i #AdBio Partners. 🔬 Amb aquesta injecció de capital la companyia continuarà desenvolupant una nova generació de teràpies per a les malalties #autoimmunes, #inflamatòries i #oncològiques.
"Fundamental research is key to better understanding the pathophysiology of diseases, bringing innovative treatment modalities and stimulating a translational approach to treat symptoms. Without strong support for basic research, translational research and company creation are likely to stagnate, hindering new solutions for patients," said Adrien Clavairoly.
Today we feature Adrien Clavairoly, Principal at #AdBio Partners (France & Spain), a venture capital firm that invests in early-stage #LifeSciences companies in Europe, scouting, building & developing #startups
#FundamentalResearch for #EUcompetitiveness
EU-LIFE #innovation ➡️ eu-life.eu/innovation
